The coronavirus vaccination will be carried out in 4 stages, which takes into account the vaccine’s availability, time of arrival, and safety profile. President Joko Widodo (Jokowi) will be the first person to receive the coronavirus vaccine injection on 13 January whereby the vaccination process will be broadcasted live. The coronavirus vaccination implementation stages are prescribed within the Director-General of Disease Prevention and Control Decree No. HK.02.02/4/1/2021 on the Technical Guidelines for Vaccination within the Context of the COVID-19 Pandemic.
Referring to the Decree published on 2 January, the priority group for the vaccines are residents domiciled in Indonesia aged 18 years and over. Meanwhile, those under 18 years of age can get vaccinated if adequate data on vaccine safety are available and approval for use during an emergency or the issuance of a distribution permit number (NIE) from the National Agency for Food and Drug Control (BPOM).
The implementation stages for the coronavirus vaccination are as follows:
Phase 1: January-April 2021
Target recipients for the 1st stage of the COVID-19 vaccination are health workers, health worker assistants, support staff, and students currently undergoing medical professional education in Health Service Facilities.
Phase 2: January-April 2021
Target recipients for Phase 2 of the COVID-19 are public service officers, namely members of the Indonesian Armed Forces (TNI)/Indonesian National Police (Polri), legal officers, and other public service officers that include government workers at airports/ports/stations/terminals, banks, state electricity companies, and regional drinking water companies, as well as others directly involved in providing services to the community; and the elderly (≥ 60 years).
Phase 3: April 2021-March 2022
Target recipients of Phase 3 of the COVID-19 vaccination are vulnerable people from geospatial, social, and economic aspects.
Phase 4: April 2021-March 2022
Target recipients for Phase 4 is the community and other economic actors by using a cluster approach according to the availability of the vaccines.
“Staging and determining priority groups for the vaccines takes into account the Roadmap of the WHO Strategic Advisory Group of Experts on Immunization (SAGE) and studies from the National Immunization Expert Advisory Committee,” said the Director-General for Disease Prevention and Control Decree No. HK.02.02/4/1/2021.
Meanwhile, the coronavirus vaccination service will take place in health service facilities owned by the central, provincial, district, and municipal governments, or those owned by the public as well as private companies that meet the requirements.
Health service facilities that conduct the coronavirus vaccinations are the public health centers (puskesmas), auxiliary puskesmas; clinics; hospitals; and the health service units at the Port Health Office (KKP). Health service facilities that implement coronavirus vaccination services must meet the following requirements:
1. Possess health workers to implement the COVID-19 vaccination.
2. Possess a cold chain facility in accordance with the type of COVID-19 vaccine used or in compliance with the prevailing law and regulations.
3. Possess an operational permit for health service facilities or a Minister of Health appointment under the prevailing laws and regulations.
“Health service facilities that cannot meet the requirements set in point 2 can become a place for the COVID-19 vaccination services but must be coordinated by the local health centers,” wrote the Director-General of Disease Prevention and Control Decree No. HK.02.02/4/1/2021.
- The Head of BPOM, Penny K. Lukito, stated that BPOM is currently continuing to oversee the process of providing the COVID-19 vaccines produced by Sinovac (CoronaVac), which is planned to be inoculated to the public in January 2021 wherein the first recipient will be President Jokowi on 13 January 2021. Penny also ensures that BPOM has monitored the quality and safety of the Sinovac or CoronaVac vaccines to be injected to President Jokowi has been maintained since the arrival of the vaccines in Indonesia on 6 December 2020 (Stage I) and 31 December 2020 (Stage II). The assurance of the quality of the Sinovac or CoronaVac vaccines to be injected to President Jokowi is by sampling and testing the vaccine. In the process of receiving the Sinovac vaccine at the airport, BPOM also checks the suitability of the documents, as well as the suitability of the temperature wherein the Sinovac or CoronaVac vaccines are stored in the Envirotainer. Another requirement of importance is in ensuring that the quality of the Sinovac vaccine according to BPOM is Lot Release, which is a requirement from the World Health Organization, in the form of an evaluation process conducted by the Drug Authorities of each country on test results and/or a review of the lot/batch quality documents of a product vaccine to ensure that the quality of each lot /batch of Sinovac vaccines. “BPOM has issued Lot Release certificates for 1.2 million Sinovac or CoronaVac vaccines that arrived on 6 December 2020. Testing in the framework of this Lot Release was carried out at the National Food and Drug Testing Development Center Laboratory,” explained Penny in a written statement (5/1).
- As per Wednesday, 6 January 2021, at 1 pm, the official number of COVID-19 positive patients in Indonesia is recorded at 779,548 with 645,746 recovered and 23,109 deaths.
Notes: Attached the daily fact sheet provided by Semar Sentinel, a subsidiary of Steinberg Protocol. Semar Sentinel is a consulting company focusing on political risks, security, and aerospace. Semar Sentinel is available to assist your company in building and assessing your contingency plan.